PINL:GRPOF - Post by User
Comment by
Lilie77on Dec 06, 2017 6:52am
109 Views
Post# 27098568
RE:Bottom line, tetra is so overdue for a 300% run it hurts
RE:Bottom line, tetra is so overdue for a 300% run it hurtsI agree, since this news from Sep 20..
This privately-owned partner, which asked to remain unnamed for the time being, has a pan-Canadian distribution network that reaches up to 7000 specialized healthcare professionals. Through their distribution channel, they have access to over 3000 specialized healthcare businesses in Canada and already work with a worldwide network of partners, including the USA.
Tetra and its partner are working together to develop a new line of products, leveraging Tetra's clinical and product development expertise. The first product will be launched in Q1 2018 with subsequent products already in development for the remainder of 2018. Tetra and its partner will be tapping into the overall Over-The-Counter (OTC) topical analgesics market of more than $300 million in sales in Canada, with the US market reaching over $2.9 billion, according to an IMS analysis. Both companies are expecting to grab a share if the specialized OTC topical analgesics market in a short period of time and could see sales generated from this distribution channel reaching $3 million for Canada in the 1st year. Since the initial launch phase will be focused on the Canadian market, further guidance will be provided as Tetra's partner gets ready to launch in the US.
Read more at https://www.stockhouse.com/news/press-releases/2017/09/20/tetra-bio-pharma-to-engage-in-co-development-and-distribution-partnership-with#VlvtYWLEwEKcioI8.99